The medical device industry faces unique challenges as PFAS begins to face regulation in the U.S. and Europe despite exceptions for medical products in most phase-out requirements.
The global at-home cancer testing market is poised for robust growth, with a projected compound annual growth rate (CAGR) of 5% from 2023 to 2033. According to a recent report by Future Market ...